Stem cell transplants are a commonly used early in treatment for eligible individuals.
This is due to advances in the way that multiple myeloma is both detected and treated. According to data from the National Cancer Institute (NCI), the 5-year relative survival rate for multiple myeloma has been improving since 1975.